← Case indexADANIENT
Adani Enterprises (NSE: ADANIENT)
Three years after Hindenburg, two years after OCCRP, eighteen months after the EDNY indictment — what the public record now shows.

| Key Fact | Detail |
|---|---|
| Report | Forensic Short — Update |
| Publication date | May 15, 2026 |
| Issuer | Adani Enterprises Ltd. (flagship of the Adani Group) |
| Ticker | NSE: ADANIENT (also BSE) |
| Domicile | India |
| Original short | Hindenburg Research — "Adani Group: How the World's 3rd Richest Man Is Pulling the Largest Con in Corporate History" (January 24, 2023) |
| ADANIENT reference price | Approximately ₹2,714 (NSE close, mid-May 2026, per public quote services) |
| Headline post-publication events | Group market-cap loss of US$100B+ in weeks following the Hindenburg report; FPO withdrawal; Supreme Court of India ruling (Jan 3, 2024); OCCRP disclosures (Aug 2023); EDNY indictment of Gautam and Sagar Adani (Nov 20, 2024); SEC settlement filing and reported DOJ move to drop criminal charges (May 2026) |
| Rating | SHORT — Update |
Why We Are Publishing Today
The Adani / Hindenburg case is one of the most consequential entries in the modern forensic-short genre — and one of the most politically charged. In May 2026 the file is, for the first time, plausibly entering a resolution phase across multiple jurisdictions:
- The US SEC has reportedly filed for court approval of a civil settlement under which Gautam Adani would pay a US$6M penalty and Sagar Adani would pay US$12M, consenting to entry of final judgment without admitting or denying allegations.
- The US Department of Justice has been reported, as of mid-May 2026, to be moving to drop the criminal fraud and bribery charges that the Eastern District of New York indicted in November 2024.
- SEBI, in September 2025, issued two "final orders" dismissing the stock-manipulation and accounting-irregularity strands of its Hindenburg-derived investigation, while continuing to investigate other allegations (notably public-shareholder classification).
- OFAC is reported to have issued a request for information following separate Wall Street Journal allegations earlier in 2026.
This Update consolidates the public record from January 2023 through mid-May 2026, integrating the May 2026 SEC settlement filing and the reported DOJ move to drop criminal charges with the prior body of evidence.
Section 1 — The Hindenburg Thesis (January 24, 2023): A Faithful Summary
Hindenburg Research's report alleged a constellation of issues at the Adani Group, of which the most analytically substantive were:
- Offshore shell-network allegations. The report identified a network of Mauritius- and other-offshore-jurisdiction entities that Hindenburg argued were beneficially controlled by, or aligned with, members of the Adani family, and which were used (per Hindenburg) to support trading in Adani Group listed securities in ways inconsistent with Indian public-shareholding rules.
- Stock-price-manipulation concerns. Hindenburg presented patterns of buying and holding in flagship listed Adani entities by the alleged related offshore funds that, in its view, did not reflect arms-length public investment.
- Accounting and audit concerns. Hindenburg flagged related-party transactions, the audit firm engaged for several flagship listed entities (Shah Dhandharia), and what it characterized as inadequate disclosure of group-level leverage.
- Conglomerate-level leverage. Hindenburg argued that the consolidated leverage of the Adani Group, taken across listed and unlisted entities, was higher than the headline figures of any one listed entity and represented a refinancing risk.
Hindenburg explicitly disclosed a short position. The Adani Group rejected the allegations in detail in a same-week 413-page response. Both sides published responses to each other's responses.
Section 2 — Market Reaction and the FPO Withdrawal
In the two-week window following Hindenburg's publication, the combined market capitalization of the Adani Group's listed entities fell by more than US$100 billion — among the sharpest market-cap drawdowns in any single corporate group on record over so brief a window.
The most immediate corporate event was the follow-on public offering (FPO) of Adani Enterprises shares, which the company had launched at the moment of the Hindenburg report. The FPO was technically fully subscribed in the final hours, primarily by large institutional and high-net-worth participants — but Adani withdrew the FPO and refunded subscribers within days, citing volatility and the interests of investors. The withdrawal was, by itself, an extraordinary event for a flagship Indian listed entity.
Bond markets reacted alongside equity. Dollar-denominated bonds across multiple Adani Group issuers traded materially wider; refinancing transactions previously scheduled were re-timed. The group later disclosed accelerated debt reduction, promoter share-pledge reductions, and a US$1.87 billion equity infusion by GQG Partners in March 2023, which became a widely-cited inflection point in the share-price recovery.
Section 3 — Indian Regulatory Response: SEBI, the Supreme Court, and the Sapre Committee
The Indian regulatory and judicial response unfolded along two tracks in parallel.
SEBI investigations. SEBI opened investigations into multiple Hindenburg-derived allegations, including alleged stock-price manipulation, alleged related-party undisclosed dealings, and alleged misclassification of certain shareholders as public. SEBI has, across subsequent disclosures, characterized its case-load as twenty-plus distinct investigations.
Supreme Court of India proceedings. Petitions filed before the Supreme Court of India sought, variously, a court-monitored Special Investigation Team (SIT) and transfer of investigation away from SEBI. The Supreme Court declined those reliefs.
The Sapre Committee. On March 2, 2023, the Supreme Court constituted a six-member expert committee chaired by former Supreme Court Justice Abhay Manohar Sapre, with members including former Justice JP Devadhar, senior advocate Somasekhar Sundaresan, senior bankers OP Bhatt and KV Kamath, and entrepreneur Nandan Nilekani. The committee was tasked with reviewing investor protection in light of the Hindenburg allegations and the regulatory response.
The Sapre Committee submitted its report to the Supreme Court in May 2023. The report, in our reading of the public summary, found no clear pattern of regulatory failure on the basis of the material then before SEBI, while noting that SEBI's continued investigation should run its course.
Supreme Court final judgment (January 3, 2024). The Supreme Court's final judgment, delivered on January 3, 2024:
- Rejected the petition for SIT-based or court-monitored transfer of the investigation away from SEBI, finding that there was no reason to displace the regulator;
- Noted that SEBI had completed approximately 22 of 24 then-open investigations and that its work "inspires confidence";
- Rejected petitioners' reliance on the OCCRP report (see Section 4) as a basis to doubt the SEBI investigation;
- Directed SEBI to complete the remaining investigations within a defined window.
SEBI's September 2025 "final orders." In September 2025, SEBI issued two "final orders" tied to specific transaction sets flagged by Hindenburg. Those orders concluded that the stock-manipulation, fund-diversion and accounting-irregularity allegations were "not established" on the material before the regulator. SEBI continued to investigate other matters, notably whether Adani Enterprises, Adani Ports, Adani Energy and Adani Power had wrongly classified certain shareholders as public for the purposes of minimum-public-shareholding (MPS) rules.
We treat the SEBI September 2025 orders as the most consequential single piece of Indian regulatory closure to date — substantively responsive to Hindenburg's central market-manipulation contention. They do not close the MPS-classification strand and they do not adjudicate any of the matters that subsequently entered the US criminal forum.
Section 4 — The OCCRP Disclosures (August 2023)
In August 2023, the Organized Crime and Corruption Reporting Project (OCCRP) — in collaboration with the Financial Times and The Guardian — published an investigation based on documents that, OCCRP reported, showed that "hundreds of millions of dollars" had been invested in publicly-traded Adani Group entities through Mauritius-based opaque investment funds allegedly managed by partners or associates of the Adani family.
The OCCRP disclosures became the most-cited "second wave" public-record contribution to the Adani case, alongside Hindenburg's own published follow-ups. The Adani Group rejected the OCCRP characterizations. The Supreme Court of India, as noted, ruled in January 2024 that the OCCRP report could not, on its own, serve as a basis to displace the SEBI investigation.
For purposes of this report, the OCCRP material is most significant because it became a substantive evidentiary input that external forums — most notably the EDNY indictment described in Section 5 — would later refer to.
Section 5 — The EDNY Indictment (November 20, 2024)
On November 20, 2024, the US Attorney for the Eastern District of New York unsealed a criminal indictment charging Gautam Adani, his nephew Sagar Adani, executive Vneet Jaain, and four executives of an Adani-affiliated counterparty entity, alongside an alleged co-conspirator from a Canadian institutional investor's renewable-energy unit. The core allegations:
- That defendants had agreed to pay, and concealed from US investors, hundreds of millions of dollars in bribes to officials in multiple Indian states to obtain solar-power purchase agreements at favorable tariffs through the Solar Energy Corporation of India (SECI);
- That, in connection with subsequent US-dollar-denominated debt and equity capital-markets transactions by Adani-affiliated entities, the bribery scheme was misrepresented or omitted, giving rise to securities-fraud counts alongside the underlying Foreign Corrupt Practices Act (FCPA) counts;
- That OCCRP-related and similar materials were among the data points alleged to have been falsely contradicted in investor-facing disclosures.
The matter was filed in the US District Court for the Eastern District of New York — not the Southern District. (We flag the venue point because much contemporaneous reporting and some earlier secondary commentary, including drafts circulated within Muddy Insights, referred imprecisely to "SDNY." The correct District is EDNY.)
The parallel SEC civil action was filed the same day and alleged related securities-fraud violations.
Adani Group response. The Adani Group rejected the indictment, characterizing the charges as "baseless" in public statements, and emphasized that none of the indicted defendants had been convicted.
Procedural status (November 2024 through May 2026). As widely reported in Indian and US media, none of the indicted defendants appeared before the EDNY court in the period following the indictment. The matter was, in consequence, effectively stalled on the criminal-procedure side.
Section 6 — The May 2026 SEC Settlement and DOJ Move to Drop Charges
The most consequential post-2024 development as of this writing is the May 2026 sequence of US events:
- The SEC has, per public reporting around May 14–15, 2026, filed for court approval of a civil settlement under which Gautam Adani would pay a US$6 million civil penalty and Sagar Adani would pay US$12 million, both consenting to entry of final judgment without admitting or denying the SEC's allegations.
- The US Department of Justice has been reported by Bloomberg, Business Today and others on May 14, 2026 to be moving to end the criminal prosecution — specifically described in public reporting as moving to drop the approximately US$265 million bribery / fraud charges against Gautam Adani in connection with the SECI solar matter.
We caution that, as of the publication date of this report, neither the SEC settlement order nor the DOJ disposition has been final-court-approved on a basis we can independently verify. The SEC filing has been made; the DOJ posture has been reported but not, to our knowledge, confirmed by an entered nolle prosequi or dismissal order. Readers should consult the EDNY docket and SEC litigation releases directly for current status before relying on this section.
We flag three open questions:
- Whether any EDNY co-defendants (i.e., parties other than the Adani principals) remain charged under the original indictment, and on what terms.
- Whether the OFAC request for information referred to in May 2026 public reporting — flowing from a separate set of Wall Street Journal allegations — develops into formal action.
- Whether SEBI's remaining MPS / public-shareholder classification investigation results in any further "final orders" in 2026.
Section 7 — Debt, Refinancing, and the GQG Investment
A characteristic of the Adani file across 2023–2026 has been the group's ability to access equity capital at moments of stress despite ongoing regulatory and criminal-procedure overhang:
- March 2023. GQG Partners' US$1.87B equity investment across multiple listed Adani entities became the symbolic inflection point of the share-price recovery and was widely cited in subsequent equity-research notes.
- 2023–2024. The group reduced promoter share pledges materially, refinanced specific US-dollar bond maturities, and signaled a shift toward lower consolidated leverage.
- 2024–2025. Capex commitments across renewable energy, ports, cement, and data centers continued, with sequential capital-markets transactions.
A reading consistent with public filings: the group's equity-market access has been broadly restored across the post-Hindenburg cycle, while its US criminal-procedure overhang has, until May 2026, remained the dominant non-domestic risk overlay.
Section 8 — Where Things Stand (May 15, 2026), and What Muddy Insights Takes From The Adani Case
As of this report's publication on May 15, 2026:
- ADANIENT trades around ₹2,714 on the NSE per mid-May 2026 quote-service data (subject to intraday revision and reader verification);
- SEBI's September 2025 final orders dismissed the stock-manipulation and accounting strands of its Hindenburg-derived investigation; the public-shareholder classification strand remains open;
- The Supreme Court of India has, since its January 2024 judgment, treated the matter as substantially closed at the apex-court level;
- The EDNY criminal matter and the SEC civil matter, both filed November 2024, appear — based on May 14–15, 2026 reporting — to be moving toward resolution favorable to the Adani principals: civil settlement on the SEC side, DOJ withdrawal on the criminal side, subject to court approval;
- OFAC has reportedly issued a request for information stemming from separate Wall Street Journal allegations earlier in 2026, the trajectory of which is presently uncertain.
What Muddy Insights takes from the Adani case as a forensic-genre study:
- The Hindenburg report is the modern reference for how to publish a structural short on a politically-connected major-market issuer. The disclosure quality and the parallel publication of supporting documentation set a procedural standard subsequent shorts have referenced.
- The case is the most-prominent example of regulator response divergence: the Indian regulator (SEBI) and the Indian apex court reached substantively different bottom-line dispositions than the US prosecutorial apparatus (EDNY / SEC) did — at least until the May 2026 reported DOJ pivot, which would partly close that divergence.
- The case illustrates the multi-jurisdiction tail risk that issuers with US-dollar capital-markets exposure carry even when their home regulator finds in their favor.
- For practitioners reading the genre: Adani is a closed-loop file in the equity-market-impact sense (the equity has recovered) and a still-open file in the legal-process sense (multiple investigations and proceedings continue).
We file Adani as a case study, not a verdict. The substantive allegations remain contested across forums, and a forensic short is not the appropriate place to adjudicate them.
Source Index (selected)
- Hindenburg Research, "Adani Group: How the World's 3rd Richest Man Is Pulling the Largest Con in Corporate History," January 24, 2023.
- Adani Group, 413-page response to Hindenburg (January 2023) and subsequent published statements.
- In re Adani-Hindenburg, Supreme Court of India — judgment of January 3, 2024.
- Report of the Expert Committee chaired by Hon. Justice (Retd.) A.M. Sapre, submitted to the Supreme Court of India, May 2023.
- Securities and Exchange Board of India — "final orders" of September 2025 on stock-manipulation, fund-diversion, and accounting strands of the Hindenburg-derived investigation.
- OCCRP / Financial Times / Guardian investigation: "Bank Documents Expose Scale of Secret Investments in Adani Group by Adani Family Associates," August 2023.
- United States v. Gautam S. Adani et al., Indictment, U.S. District Court for the Eastern District of New York, unsealed November 20, 2024.
- US Securities and Exchange Commission, Litigation Release No. LR-26177 (Gautam Adani, Sagar Adani, Cyril Cabanes), and subsequent SEC filings through May 2026.
- US Department of Justice, EDNY press release, November 20, 2024.
- Public reporting on the May 14–15, 2026 SEC settlement filing and reported DOJ move to drop criminal charges (Bloomberg, CNBC, Business Today, The Week, others).
- Public reporting on the OFAC request for information following 2026 WSJ allegations.
— Muddy Insights, May 15, 2026.
// More files
- 0282026-10-21CURRCURR · 2026-10-21Currenc Group Inc. (NASDAQ: CURR) — Forensic FileA Charging Order Over The Only Asset That Matters. The Same 100,465 Tranglo Shares Sold For US$400M Are Now Charged To A Judgment Creditor.NOT RATED — Forensic FileNOT RATED — Forensic File
- 0272026-07-21DLXYDLXY · 2026-07-21Delixy Holdings Ltd. (NASDAQ: DLXY) — Forensic Short ReportThe IPO Funded An Exit, Not An Expansion. Dividends Out 4x What The Public Put In.NOT RATED — Research case studyNOT RATED — Research case study
- 0262026-07-15TROOTROO · 2026-07-15TROOPS, Inc. (NASDAQ: TROO) — Forensic Short UpdateThe August 20 Endgame: Winding-Up Exposure, Suspension Mechanics, And A Support Bid Running On FumesSHORT — High convictionSHORT — High conviction
- 0252026-05-05TROOTROO · 2026-05-05TROOPS, Inc. (NASDAQ: TROO) — Forensic Short UpdateAuditor Replaced. Lock-Up Eased. Annual Report Past Due.SHORT — High convictionSHORT — High conviction
- 0242026-04-15TRETRE · 2026-04-15Sino-Forest Corporation (TSX: TRE)The founding case of the modern China-short genre — fifteen years on.SHORT — Closed CaseSHORT — Closed Case
- 0232026-03-30BURBUR · 2026-03-30Burford Capital (NYSE/LSE: BUR)Six years on from Muddy Waters' mismarking thesis — what the Second Circuit's March 2026 reversal of the YPF judgment changes.NEUTRALNEUTRAL
- 0222026-02-25IEPIEP · 2026-02-25Icahn Enterprises L.P. (NASDAQ: IEP)Three years after Hindenburg's "Pied Piper of Pumpland" — distributions, the SEC settlement, and the margin-loan unwind.SHORT — UpdateSHORT — Update
- 0212026-02-01WDIWDI · 2026-02-01Wirecard AG (XETRA: WDI) — Closed-Case RetrospectiveSix years after the €1.9B missing cash — what a streamlined trial, a €140M civil award, and the Marsalek-as-FSB-asset disclosures now confirm.SHORT — Closed CaseSHORT — Closed Case
- 0202026-01-15NKLANKLA · 2026-01-15Nikola Corporation (NASDAQ: NKLA)The Hindenburg short, the Milton conviction, the Trump pardon, and the company's own Chapter 11.SHORT — Closed CaseSHORT — Closed Case
- 0192025-12-02MAGHMAGH · 2025-12-02Magnitude International Ltd. (NASDAQ: MAGH) — Forensic ShortPenny-Priced Pre-IPO Equity, Eight-Month Cashout, Resale Shelf Engineered for Insider Exit.SHORT — High convictionSHORT — High conviction
- 0182025-10-21VRXVRX · 2025-10-21Valeant Pharmaceuticals (NYSE: VRX, now Bausch Health: BHC)Citron's "Pharmaceutical Enron" call, the Philidor disclosure, and the ten-year recovery that never came.SHORT — Closed CaseSHORT — Closed Case
- 0172025-09-01TIOTIO · 2025-09-01Tingo Group (NASDAQ: TIO)Hindenburg's June 2023 short, SEC fraud charges, the $250M civil judgment, and the founder still at large.SHORT — Closed CaseSHORT — Closed Case
- 0162024-09-15EBIXEBIX · 2024-09-15Ebix, Inc. (NASDAQ: EBIX)Hindenburg's June 2021 short, the December 2023 Chapter 11, the $400M Zinnia sale, and the August 2024 emergence under Eraaya LifeSpaces sponsorship.SHORT — UpdateSHORT — Update
- 0152024-07-15FFGRPFFGRP · 2024-07-15Folli Follie (ATHEX: FFGRP)QCM's May 2018 short, the largest stock-market fraud in modern Greek history, and the June 2024 prison sentences.SHORT — Closed CaseSHORT — Closed Case
- 0142024-04-15SNHSNH · 2024-04-15Steinhoff International (JSE: SNH)Viceroy's December 2017 short, €7B+ of confirmed accounting irregularities, and the July 2023 vote to dissolve.SHORT — Closed CaseSHORT — Closed Case
- 0132024-04-01RIDERIDE · 2024-04-01Lordstown Motors (NASDAQ: RIDE, now Nu Ride: NRDE)From SPAC pre-orders to Chapter 11 to a litigation-vehicle reorganization.SHORT — Closed CaseSHORT — Closed Case
- 0122022-09-15GSXGSX · 2022-09-15GSX Techedu (NYSE: GSX, now Gaotu: GOTU)Muddy Waters' May 2020 short, the July 2021 "double reduction" policy that vindicated the broader sector thesis, and the 2022 HFCAA delisting.SHORT — Closed CaseSHORT — Closed Case
- 0112022-05-15EROSEROS · 2022-05-15Eros International / Eros STX Global (NYSE: EROS, formerly)Kerrisdale's November 2015 short, the 2020 merger with STX Entertainment, and the 2022 separation that effectively ended the listed parent.SHORT — Closed CaseSHORT — Closed Case
- 0102021-09-15QPPQPP · 2021-09-15Quindell PLC (LSE AIM: QPP, now Watchstone)Gotham City Research's April 2014 short, the £637M Slater & Gordon sale, the £11M settlement that followed, and the SFO investigation that ended without charge.SHORT — Closed CaseSHORT — Closed Case
- 0092020-10-15SONGSONG · 2020-10-15Akazoo S.A. (NASDAQ: SONG)QCM's April 2020 short, SEC fraud charges, and the fastest US-regulator resolution of a SPAC-era fraud.SHORT — Closed CaseSHORT — Closed Case
- 0082020-02-15INSYINSY · 2020-02-15Insys Therapeutics (NASDAQ: INSY)Citron's August 2016 short, the Subsys opioid-marketing prosecution, the June 2019 bankruptcy, and the first US pharmaceutical-executive RICO conviction for opioid marketing.SHORT — Closed CaseSHORT — Closed Case
- 0072020-01-15ONON · 2020-01-15Bio-on S.p.A. (Borsa Italiana AIM: ON) — Forensic Short Closed CaseAuditor-quality bioplastics revenue, a same-quarter founder arrest, and the fastest closure of any modern European forensic-short case.SHORT — Closed CaseSHORT — Closed Case
- 0062019-01-15N21N21 · 2019-01-15Noble Group (SGX: N21)Iceberg Research's February 2015 short, multi-year mark-to-model contestation, and the 2018 break-up of one of Asia's largest commodity traders.SHORT — Closed CaseSHORT — Closed Case
- 0052018-01-15NQNQ · 2018-01-15NQ Mobile (NYSE: NQ)Muddy Waters' October 2013 short, four years of contested public posture, and the eventual NYSE delisting in 2017.SHORT — Closed CaseSHORT — Closed Case
- 0042015-09-15FMCNFMCN · 2015-09-15Focus Media (NASDAQ: FMCN, formerly)Muddy Waters' November 2011 short, the 2013 take-private at a premium, and the 2015 China A-share relisting at a multiple of the take-private price.SHORT — Counter-CaseSHORT — Counter-Case
- 0032014-08-01GOWGOW · 2014-08-01Let's Gowex (BME MAB: GOW)Gotham City Research's July 2014 short, the CEO confession within days, and the fastest forensic-short to bankruptcy in the modern catalogue.SHORT — Closed CaseSHORT — Closed Case
- 0022013-12-15CCMECCME · 2013-12-15China MediaExpress Holdings (NASDAQ: CCME)Muddy Waters' February 2011 short, auditor Deloitte's resignation, and the SEC fraud charges that followed.SHORT — Closed CaseSHORT — Closed Case
- 0012013-12-15LFTLFT · 2013-12-15Longtop Financial Technologies (NYSE: LFT)Citron's April 2011 short, Deloitte's May 2011 resignation letter, and the SEC's signature fraud case of the 2011 China-short wave.SHORT — Closed CaseSHORT — Closed Case